2NAKAMURA H, KATO H. Oncogenic emergencies: appropriate treatment in lung cancer[ J]. Nippon Geka Gakkai Zasshi,2004, 105(4) :271 -274.
3GERSZTEN PC, MONACO EA 3RD. Complete percutaneous treatment of vertebral body tumors causing spinal canal compromise using a transpedicular cavitation, cement augmentation, and radio- surgical technique [ J ]. Neurosurg Focus,2009,27 ( 6 ) : E9.
4SCHMIDT LA, PFEIFFER P. Metastatic spinal cord compression syndrome. A retrospective analysis of 297 patients [ J ]. Ugeskr Laeger, 2006,168 (34) :2810 - 2813.
5SHEPHERD FA, RODRIGUES PEREIRA J, CIULEANU T, et al. Erlotinib in previously treated non-small-cell lung cancer[ J]. N Engl J Med,2005,353(2) :123 - 132.
6THATCHER N, CHANG A, PARIKH P,et al. Gefitinib plus best supportive care in previously treated patients with refractory ad- vanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) [ J ]. Lancet ,2005,366 (9496) : 1527 - 1537.
